Clarity Pharmaceuticals Eulerpool Ziņas

Clarity Pharmaceuticals Eulerpool News

Clarity Pharmaceuticals Akciju Ziņas

Clarity Pharmaceuticals tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Clarity Pharmaceuticals ziņas mēs apkopojam šeit.

• 1. jūnijs ·

  Yahoo
  Is Clarity Pharmaceuticals Ltd (ASX:CU6) Trading At A 48% Discount?
• 15. marts ·

  Yahoo
  Clarity's theranostic prostate cancer trial advances to multi-dose phase
• 8. marts ·

  Yahoo
  Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range
• 22. decembris ·

  Yahoo
  First patient dosed in Clarity's registrational Phase III prostate cancer trial with Cu-64 SAR-bisPSMA
• 30. novembris ·

  Yahoo
  Registrational Phase III CLARIFY trial in prostate cancer commences
• 30. novembris ·

  Yahoo
  First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level
• 7. novembris ·

  Yahoo
  Recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial
• 26. oktobris ·

  Yahoo
  Clarity and PSI kick off SAR-bisPSMA Phase III
• 3. oktobris ·

  Yahoo
  First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial
• 10. augusts ·

  Yahoo
  Clarity's theranostic prostate cancer trial advances to highest dose level